Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00787 vosoritide (Voxzogo)PayerPolicy · BCBSLA-00787-9987B25C6A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00786 inclisiran (Leqvio)PayerPolicy · BCBSLA-00786-5AFE2EB348 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00785 Dartisla ODT (glycopyrrolate orally disintegrating tablets)PayerPolicy · BCBSLA-00785-790EC2C805 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00784 Livtencity (maribavir)PayerPolicy · BCBSLA-00784-B9C0BBF2CE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00783 odevixibat (Bylvay)PayerPolicy · BCBSLA-00783-51B4628E37 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00782 Select Meclizine ProductsPayerPolicy · BCBSLA-00782-2B77584A0B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00781 allogeneic thymocyte-depleted thymus tissue-agdc (Rethymic)PayerPolicy · BCBSLA-00781-2D5ADB6038 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00780 Bioimpedance Devices for LymphedemaPayerPolicy · BCBSLA-00780-E424887B31 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00779 Laser Interstitial Thermal Therapy for Neurological ConditionsPayerPolicy · BCBSLA-00779-86E4D2BC1D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00778 Select Ursodiol ProductsPayerPolicy · BCBSLA-00778-B070333B69 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00777 Select Chlorthalidone Tablet StrengthsPayerPolicy · BCBSLA-00777-ED84289D9C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00776 Pharmacotherapy for PresbyopiaPayerPolicy · BCBSLA-00776-D5E900A32A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00775 maralixibat (Livmarli)PayerPolicy · BCBSLA-00775-29F185911C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00774 ruxolitinib (Opzelura)PayerPolicy · BCBSLA-00774-25AD271E3B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00773 Loreev XR (lorazepam extended release)PayerPolicy · BCBSLA-00773-8FD64AB945 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00772 avacopan (Tavneos)PayerPolicy · BCBSLA-00772-C3551EB110 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00771 Pharmacotherapy for Pompe DiseasePayerPolicy · BCBSLA-00771-4707A687F8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00770 Experimental-Investigational ServicesPayerPolicy · BCBSLA-00770-ECC4D0A57F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00769 Vertebral Body Stapling and Vertebral Body Tethering for the Treatment of ScoliosisPayerPolicy · BCBSLA-00769-9FB55090CD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00768 pegcetacoplan (Empaveli)PayerPolicy · BCBSLA-00768-44CFEFEC71 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00767 anifrolumab (Saphnelo)PayerPolicy · BCBSLA-00767-D93C41432F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00766 Brexafemme (ibrexafungerp)PayerPolicy · BCBSLA-00766-F514868FC6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00765 Kerendia (finerenone)PayerPolicy · BCBSLA-00765-B906FDAD75 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00764 Zegalogue (dasiglucagon)PayerPolicy · BCBSLA-00764-DF21AEC951 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00763 ivermectin tablets (Stromectol, generics)PayerPolicy · BCBSLA-00763-BD0F57DD3A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00762 emtricitabine/tenofovir disoproxil fumarate (Truvada)PayerPolicy · BCBSLA-00762-B55E00AC59 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00761 Cromolyn Oral Solution (Gastrocrom, generics)PayerPolicy · BCBSLA-00761-6793496DD2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00760 glatiramer acetate (Copaxone)PayerPolicy · BCBSLA-00760-A947448EB0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00759 Beta Interferons for the Treatment of Multiple SclerosisPayerPolicy · BCBSLA-00759-3A18BAD1B4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00758 teriflunomide (Aubagio, generics)PayerPolicy · BCBSLA-00758-955BF4FD2B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00757 Adjunctive Techniques for Screening and Surveillance of Barrett Esophagus and Esophageal DysplasiaPayerPolicy · BCBSLA-00757-95715AF031 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00756 Mobile Device-Based Health Management ApplicationsPayerPolicy · BCBSLA-00756-FB0BD5F11F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00755 Digital Health Therapies for Attention Deficit/Hyperactivity Disorder- Retired PolicyPayerPolicy · BCBSLA-00755-A66E19007F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00754 Monoclonal Antibodies for the Treatment of Alzheimer’s DiseasePayerPolicy · BCBSLA-00754-AC96D84D7F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00753 fosdenopterin (Nulibry)PayerPolicy · BCBSLA-00753-F1A8862770 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00752 Verquvo (vericiguat)PayerPolicy · BCBSLA-00752-76BF2970F8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00751 evinacumab-dgnb (Evkeeza)PayerPolicy · BCBSLA-00751-3E37F41555 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00750 Allograft Injection for Degenerative Disc DiseasePayerPolicy · BCBSLA-00750-71EC233D0A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00749 ponesimod (Ponvory)--Retired PolicyPayerPolicy · BCBSLA-00749-C430B9CD65 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00748 voclosporin (Lupkynis)PayerPolicy · BCBSLA-00748-E2ED572AD9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00747 naxitamab (Danyelza)PayerPolicy · BCBSLA-00747-08196AC6A0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00746 Pharmacotherapy for primary hyperoxaluria Type 1 (PH1)PayerPolicy · BCBSLA-00746-94FD14BCD1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00745 Select Combination Products for the Treatment of H. pylori InfectionPayerPolicy · BCBSLA-00745-F1C0589040 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00744 Hemady (dexamethasone)PayerPolicy · BCBSLA-00744-C03E45FAC4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00743 berotralstat (Orladeyo)PayerPolicy · BCBSLA-00743-0BE4A9393F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00742 Select Oral Hydrocortisone ProductsPayerPolicy · BCBSLA-00742-FA489CF447 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00741 Gimoti (metoclopramide nasal spray)PayerPolicy · BCBSLA-00741-EAAFB2E450 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00740 Ortikos (budesonide extended release capsules 6mg, 9mg)- Retired PolicyPayerPolicy · BCBSLA-00740-E074F20641 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00739 fostemsavir (Rukobia)PayerPolicy · BCBSLA-00739-7352EA3BD0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00738 Select Tramadol ProductsPayerPolicy · BCBSLA-00738-94BCE6EC5C | New policy |
|---|